InvestorsHub Logo
Followers 34
Posts 3031
Boards Moderated 0
Alias Born 02/27/2016

Re: RedShoulder post# 409163

Thursday, 03/30/2023 6:17:26 PM

Thursday, March 30, 2023 6:17:26 PM

Post# of 470679
Yep and that’s precisely why Missling brought in Perry and Grimmer. For them to tell us that it’s a no brainer to prescribe Blarcamesine over Leqembi. To point out how much better we are and how less cumbersome it is to just pop a pill.

He was saying. Hello. This is a no brainer and that’s why he said aggressively pursuing an accelerated approval. Telling us. Ha! Did you see what they just approved. Are you kidding me. This is an easy layup.

So he showed us the unconventional odds ratio and the CDR SB to say. Look you want a slower decline? That’s what we have and with some improvement to boot.

So we say. A slowing of decline isn’t good enough. We want more data! Let’s say even if it is a smaller N than we wanted. Is that bad? That some people benefit and some improve and countries save billions and billions and families get an improved QOL for people they love?

No. We need to see the N. We want more people to improve. Otherwise it’s not good enough. Because some people improving is NOT better than none?? Huh. Don’t really get that. Do other regulatory bodies make decisions based on less common sense than I just laid out? I’m thinking no.

When there’s nothing and more nothing and then costly crap with adverse effects, we look like the most beautiful girl in the room wearing a dress of safety and nine inch heels with more safety. But but but it was odds ratio. Only odds ratio. We need more. Ha!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News